跳轉至內容
Merck
全部照片(1)

文件

PZ0004

Sigma-Aldrich

伐尼克兰 酒石酸酯

≥98% (HPLC)

同義詞:

7,8,9,10-四氢-6,10-亚甲基-6H-吡嗪并[2,3-h][3]苯并氮杂卓 酒石酸酯, 酒石酸伐仑克林

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C13H13N3 · C4H6O6
CAS號碼:
分子量::
361.35
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: >5 mg/mL

儲存溫度

room temp

SMILES 字串

O[C@H]([C@@H](O)C(O)=O)C(O)=O.C1NC[C@H]2C[C@@H]1c3cc4nccnc4cc23

InChI

1S/C13H13N3.C4H6O6/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;5-1(3(7)8)2(6)4(9)10/h1-2,4-5,8-9,14H,3,6-7H2;1-2,5-6H,(H,7,8)(H,9,10)/t8-,9+;1-,2-/m.1/s1

InChI 密鑰

TWYFGYXQSYOKLK-CYUSMAIQSA-N

應用

酒石酸伐伦克林已被用于研究其在预脉冲抑制(PPI)下对大鼠感觉运动门控的作用。 它适合用作参考标准品,通过毛细管等速电泳(ITP)和毛细管区带电泳(CZE)在线耦合对尿液样本中的伐伦克林代谢产物进行定量。 它也适用于测试其对大鼠运动和非运动行为缺陷的作用。

生化/生理作用

酒石酸伐伦克林是一种部分α4β2烟碱样受体激动剂和α7完全激动剂。伐伦克林可竞争性地与α4β2受体结合,并在不产生完全尼古丁效应的情况下进行部分刺激,同时阻断尼古丁与受体结合的能力。因此,伐伦克林可阻断尼古丁激活α4β2受体并刺激中枢中脑边缘多巴胺系统的能力,这被认为是吸烟后增强和获得奖赏的神经元机制。

特點和優勢

该化合物在受体分类和信号转导手册的乙酰胆碱受体(烟碱型)页面上有详细描述。想要浏览手册的其他页面, 请单击此处
这种化合物是ADME毒性研究的特色产品。点击此处发现更多特色ADME毒性产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

象形圖

Exclamation markEnvironment

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Acute 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Nathan M Holmes et al.
Addiction biology, 24(5), 849-859 (2018-06-20)
Restricting when and where smoking can occur is a major focus of public health policies in Western countries. In conjunction with increased taxation, these approaches have contributed to a reduction in smoking uptake among adolescents, yet the consequences for established
Hiroyuki Mizoguchi et al.
Behavioural brain research, 359, 935-941 (2018-06-24)
Patients suffering from neuropsychiatric disorders such as substance use and addiction disorders show impaired decision-making, which may be associated with their psychiatric disorders. Previously, using a gambling test for rodents, we demonstrated that methamphetamine-dependent rats showed alterations in their decision-making
Elizabeth G Guy et al.
Behavioural pharmacology, 25(8), 775-783 (2014-09-18)
Smoking tobacco remains one of the leading causes of preventable deaths in North America. Nicotine reinforces smoking behavior, in part, by enhancing the reinforcing properties of reward-related stimuli, or conditioned stimuli (CSs), associated with tobacco intake. To investigate how pharmaceutical
Yi-Hsuan Chuang et al.
Cancers, 12(5) (2020-05-28)
Although many studies have shown the association between smoking and the increased incidence and adverse prognosis of head and neck squamous cell carcinoma (HNSCC), the mechanisms and pharmaceutical targets involved remain unclear. Here, we integrated gene expression signatures, genetic alterations
Andrea de Bejczy et al.
Alcoholism, clinical and experimental research, 39(11), 2189-2199 (2015-09-29)
Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α4 β2 nicotinic acetylcholine receptors. A

文章

Sigma-Aldrich针对您的研究需求提供了许多烟碱型乙酰胆碱受体相关的产品。

Sigma-Aldrich offers many products related to nicotinic acetylcholine receptors for your research needs.

Discover Bioactive Small Molecules for ADME/Tox

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務